Resumo

CANENCIA MALDONADO, F.; GONZALEZ SALADO, H.; APARICIO HERNANDEZ, R.  e  GARCIA LUQUE, A.. Possitive assesment of drugs: December 2015, January and February 2016. Sanid. Mil. [online]. 2016, vol.72, n.2, pp.110-115. ISSN 1887-8571.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in December of 2015, January and February of 2016, and considered of interest to the healthcare profesional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Albutrepenonacog Alfa; Idelvion^®; Dexametasona; Neofordex^®; Eftrenonacog Alfa; Alprolix^®; Elotuzumab; Empliciti^®; Emtricitabina/Tenofovir alafenamida; Descovy^®; Factor de coagulación X humano; Coagadex^®; Ixekizumab; Taltz^®; Lesinurad; Zurampic^®; Maltol férrico; Feraccru^®; Necitumumab; Portrazza^®; Octocog Alfa; Iblias/Kovaltry^®; Osimertinib; Tagrisso^®; Selexipag; Uptravi^®; Trifluridina/Tiperacilo; Lonsurf^®.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )